These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21251896)

  • 1. The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension.
    Kandavar R; Higashi Y; Chen W; Blackstock C; Vaughn C; Sukhanov S; Sander GE; Roffidal LE; Delafontaine P; Giles TD
    J Am Soc Hypertens; 2011; 5(3):161-5. PubMed ID: 21251896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital plethysmography and arginine metabolism in prehypertension: effect of nebivolol therapy.
    Kandavar R; Fernandez C; Sander GE; Kim C; Velaga S; Sukhanov S; Delafontaine P; Egan P; Roffidal LE; Giles TD
    J Clin Hypertens (Greenwich); 2015 Jan; 17(1):14-9. PubMed ID: 25495953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
    Hillebrand U; Lang D; Telgmann RG; Hagedorn C; Reuter S; Kliche K; Stock CM; Oberleithner H; Pavenstädt H; Büssemaker E; Hausberg M
    J Hypertens; 2009 Mar; 27(3):517-26. PubMed ID: 19330906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular effects of nebivolol added to hydrochlorothiazide in African Americans with hypertension and echocardiographic evidence of diastolic dysfunction: the NASAA study.
    Khan BV; Rahman ST; Haque T; Merchant N; Bhaheetharan S; Harris J; Umar K; Wahi J; Ferdinand KC
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):291-7. PubMed ID: 22388001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial.
    Lewin A; Punzi H; Luo X; Stapff M
    Clin Ther; 2013 Feb; 35(2):142-52. PubMed ID: 23332366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
    Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
    Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
    Brixius K; Middeke M; Lichtenthal A; Jahn E; Schwinger RH
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.
    Wang Y; Zhang M; Liu Y; Liu Y; Chen M
    Vascul Pharmacol; 2011; 54(1-2):36-43. PubMed ID: 21167314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.
    Sen N; Tavil Y; Erdamar H; Yazici HU; Cakir E; Akgül EO; Bilgi C; Erbil MK; Poyraz F; Okyay K; Turfan M; Cemri M
    Anadolu Kardiyol Derg; 2009 Oct; 9(5):371-9. PubMed ID: 19819787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension.
    Okamoto LE; Gamboa A; Shibao CA; Arnold AC; Choi L; Black BK; Raj SR; Robertson D; Biaggioni I
    Hypertension; 2014 Dec; 64(6):1241-7. PubMed ID: 25267802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.
    Garbin U; Pasini AF; Stranieri C; Manfro S; Boccioletti V; Cominacini L
    Pharmacol Res; 2007 Dec; 56(6):515-21. PubMed ID: 17977009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: a pharmacoeconomic comparison of antihypertensive efficacy of beta blockers.
    Patel RS; Sharma KH; Kamath NA; Patel NH; Thakkar AM
    Indian J Pharmacol; 2014; 46(5):485-9. PubMed ID: 25298575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
    Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
    Pesant Y; Marc-Aurèle J; Bielmann P; Alaupovic P; Cartier P; Bichet D; Thibault G; Lupien PJ
    Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of nebivolol and metoprolol on arterial stiffness, circulating progenitor cells, and oxidative stress.
    Hayek SS; Poole JC; Neuman R; Morris AA; Khayata M; Kavtaradze N; Topel ML; Binongo JG; Li Q; Jones DP; Waller EK; Quyyumi AA
    J Am Soc Hypertens; 2015 Mar; 9(3):206-13. PubMed ID: 25681236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells.
    Ladage D; Brixius K; Hoyer H; Steingen C; Wesseling A; Malan D; Bloch W; Schwinger RH
    Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):720-4. PubMed ID: 16895546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension.
    Serg M; Kampus P; Kals J; Zagura M; Zilmer M; Zilmer K; Kullisaar T; Eha J
    Scand J Clin Lab Invest; 2012 Sep; 72(5):427-32. PubMed ID: 22708640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients.
    Zanchetti A
    Blood Press Suppl; 2004 Oct; 1():17-32. PubMed ID: 15587108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.